Brief: Vir Biotechnology Appoints Executive Vice President And Chief Scientific Officer
30/10/2023 12:12
Oct 30 (Reuters) - Vir Biotechnology Inc VIR.O :
* VIR BIOTECHNOLOGY APPOINTS JENNIFER TOWNE, PH.D., AS
EXECUTIVE
VICE PRESIDENT AND CHIEF SCIENTIFIC OFFICER
Source text for Eikon: ID:nBwXzRqJa
Further company coverage: VIR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vir Biotechnology
See all newsVir, Gilead team up on solid tumor cancer therapies in up to $1.9 billion deal
Vir Biotechnology gains after up to $1.9 billion licensing deal with Gilead
Brief: Vir Biotechnology Announces Psma-Targeted Pro-Xten® Dual-Masked T-Cell Engager Vir-5500 Received FDA Fast Track Designation For The Treatment Of Prostate Cancer
Brief: Vir Biotechnology Appoints David Liu As Chief Medical Officer
Vir Biotechnology rises after naming Theravance's Sawaf as CFO